Withdrawal of shunt systems - clinical use of the programmable shunt system and its effect on hydrocephalus in children

被引:19
|
作者
Takahashi, Y [1 ]
机构
[1] Hokkaido Childrens Hosp & Med Ctr, Dept Pediat Neurosurg, Hokkaido, Japan
关键词
children; hydrocephalus; shunt; programmable valve; withdrawal of shunt; outcome;
D O I
10.1007/s003810000424
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objects: The most important function of the programmable valve (PV) is to limit the shunt-dependent flow of the cerebrospinal fluid by upgrading valve pressure. This activates the regular circulation of cerebrospinal fluid, which may make successful removal of the shunt possible once sufficient cerebral development has been achieved. The purpose of this paper is to indicate the possibility of shunt removal using the programmable Medos and Sophy valves (one programmable Sophy valve was specially designed for this situation). Methods: Prior to regular use of the PV, removal of existing shunt systems was attempted in 57 children, since some systems malfunctioned and others had abdominal tubes that were meanwhile too short as the children had grown as they became older. Shunt removal was successfully achieved in only 18 patients (32%). However, in patients in whom PV valves were used, shunt removal was successful in 68 out of 114 patients (57%). This shows that the success rate of shunt removal becomes significantly higher when PV valves are used. The 68 cases in which PV valves were used and shunt removal was successful were divided into three groups: A, B, and C. In group A (36 cases, 53%), the Medos valve was used for the initial PV shunt implantation and the pressure was gradually increased up to 200 mmH(2)O. The shunt systems were then withdrawn. Group B (29 cases, 43%) includes patients who experienced both the minor symptoms and ventricular enlargement attributable to increased valve pressure. The pressure was gradually upgraded by pumping several times and was maintained at close to 200 mmH(2)O. After 6-24 months' observation shunt removal was performed, and in 21 out of 29 cases the outcome was good. However, the remaining 8 patients (12%) still had symptoms and required shunt reinsertion. The specially designed Sophy valves were then used, which allowed the pressure to be set at above 200 mmH(2)O. The pressure was increased by degrees up to 400 mmH(2)O and kept at the same level for 6-24 months. The shunt systems were then removed successfully. Although a high pressure setting was required over a sustained period, a total of 29 patients (43%) were able to have their shunts removed. In group C (3 cases, 4%), which included patients with aqueduct stenosis. the pressure was raised and thus allowed ventricle enlargement. Third ventriculostomy was performed under neuroendoscopy with the shunt pressure maintained at a high level. Shunt systems were removed successfully. Conclusions: This study showed that it is possible to remove the shunt systems in 50% or more of pediatric hydrocephalus cases in which PV valves are used. This is achieved through careful control of the valve pressure. Close observation is essential during the period when the PV pressure is maintained at a high level, as well as 6-12 months after shunt removal.
引用
收藏
页码:472 / 477
页数:6
相关论文
共 50 条
  • [31] IS THERE A REASONABLE DIFFERENTIAL INDICATION FOR DIFFERENT HYDROCEPHALUS SHUNT SYSTEMS
    TROST, HA
    CHILDS NERVOUS SYSTEM, 1995, 11 (04) : 189 - 192
  • [32] Investigation of the hydrodynamic properties of a new MRI-resistant programmable hydrocephalus shunt
    Allin D.M.
    Czosnyka M.
    Richards H.K.
    Pickard J.D.
    Czosnyka Z.H.
    Cerebrospinal Fluid Research, 5 (1):
  • [33] Electroconvulsive therapy for depression in a patient with a programmable ventriculoperitoneal shunt in situ for congenital hydrocephalus
    Whittle, Caed
    Eghbal, Aaida
    Pilkington, Adam
    Akram, Kehaan
    Hollingworth, Milo A.
    BRITISH JOURNAL OF NEUROSURGERY, 2025,
  • [34] The use of image intensification in the management of "programmable" shunt valves
    R Strachan
    R Bore
    Cerebrospinal Fluid Research, 1 (Suppl 1):
  • [35] Reevaluating the weekend effect on patients with hydrocephalus undergoing operative shunt intervention
    Attenello, Frank J.
    Christian, Eisha
    Wen, Timothy
    Cen, Steven
    Zada, Gabriel
    Kiehna, Erin N.
    Krieger, Mark D.
    McComb, J. Gordon
    Mack, William J.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2016, 17 (02) : 156 - 162
  • [36] Cerebrospinal fluid biomarkers of neuroinflammation in children with hydrocephalus and shunt malfunction
    Carolyn A. Harris
    Diego M. Morales
    Rooshan Arshad
    James P. McAllister
    David D. Limbrick
    Fluids and Barriers of the CNS, 18
  • [37] Z FLOW HYDROCEPHALUS SHUNT, A NEW APPROACH TO THE PROBLEM OF HYDROCEPHALUS, THE RATIONALE BEHIND ITS DESIGN AND THE INITIAL RESULTS OF PRESSURE MONITORING AFTER Z FLOW SHUNT IMPLANTATION
    CHHABRA, DK
    AGRAWAL, GD
    MITTAL, P
    ACTA NEUROCHIRURGICA, 1993, 121 (1-2) : 43 - 47
  • [38] Screening for ventricular shunt function in children with hydrocephalus secondary to meningomyelocele
    Liptak, GS
    Bolander, HM
    Langworthy, K
    PEDIATRIC NEUROSURGERY, 2001, 34 (06) : 281 - 285
  • [39] Cerebrospinal fluid biomarkers of neuroinflammation in children with hydrocephalus and shunt malfunction
    Harris, Carolyn A.
    Morales, Diego M.
    Arshad, Rooshan
    McAllister, James P., II
    Limbrick, David D., Jr.
    FLUIDS AND BARRIERS OF THE CNS, 2021, 18 (01)
  • [40] Treating Hydrocephalus with Retrograde Ventriculosinus Shunt: Prospective Clinical Study
    Baert, Edward Jozef
    Dewaele, Frank
    Vandersteene, Jelle
    Hallaert, Giorgio
    Kalala, Jean-Pierre O.
    Van Roost, Dirk
    WORLD NEUROSURGERY, 2018, 118 : E34 - E42